Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

administration of dexamethasone intravenously

PreclinicalSmall molecule

PPontificia Universidad Catolica de Chile

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q4 2027

PreclinicalRecruiting

Pain

NCT07324499

Clinical

Trials by Indication[1]

Pain1 trial

Effect of Dexamethasone on Plasma Levels of Bupivacaine and Dexamethasone Following a Single-injection Interscalene Nerve Block: A Randomized Controlled Study

Recruiting·PPontificia Universidad Catolica de Chile·Preclinical·NCT07324499·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for administration of dexamethasone intravenously. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — administration of dexamethasone intravenously compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for administration of dexamethasone intravenously. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pontificia Universidad Catolica de Chile company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: PPontificia Universidad Catolica de Chile

Related News